GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » InfuSystems Holdings Inc (FRA:1TZ) » Definitions » Cyclically Adjusted Revenue per Share

InfuSystems Holdings (FRA:1TZ) Cyclically Adjusted Revenue per Share : €4.42 (As of Mar. 2024)


View and export this data going back to 2021. Start your Free Trial

What is InfuSystems Holdings Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

InfuSystems Holdings's adjusted revenue per share for the three months ended in Mar. 2024 was €1.387. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is €4.42 for the trailing ten years ended in Mar. 2024.

During the past 12 months, InfuSystems Holdings's average Cyclically Adjusted Revenue Growth Rate was 8.20% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 10.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 9.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of InfuSystems Holdings was 10.30% per year. The lowest was 3.80% per year. And the median was 7.60% per year.

As of today (2024-06-23), InfuSystems Holdings's current stock price is €5.95. InfuSystems Holdings's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was €4.42. InfuSystems Holdings's Cyclically Adjusted PS Ratio of today is 1.35.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of InfuSystems Holdings was 6.41. The lowest was 0.46. And the median was 1.81.


InfuSystems Holdings Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for InfuSystems Holdings's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InfuSystems Holdings Cyclically Adjusted Revenue per Share Chart

InfuSystems Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 3.29 3.82 4.18

InfuSystems Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.87 4.06 4.35 4.18 4.42

Competitive Comparison of InfuSystems Holdings's Cyclically Adjusted Revenue per Share

For the Medical Instruments & Supplies subindustry, InfuSystems Holdings's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InfuSystems Holdings's Cyclically Adjusted PS Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, InfuSystems Holdings's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where InfuSystems Holdings's Cyclically Adjusted PS Ratio falls into.



InfuSystems Holdings Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, InfuSystems Holdings's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=1.387/131.7762*131.7762
=1.387

Current CPI (Mar. 2024) = 131.7762.

InfuSystems Holdings Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.538 100.560 0.705
201409 0.573 100.428 0.752
201412 0.571 99.070 0.760
201503 0.686 99.621 0.907
201506 0.661 100.684 0.865
201509 0.714 100.392 0.937
201512 0.746 99.792 0.985
201603 0.713 100.470 0.935
201606 0.698 101.688 0.905
201609 0.667 101.861 0.863
201612 0.706 101.863 0.913
201703 0.728 102.862 0.933
201706 0.663 103.349 0.845
201709 0.648 104.136 0.820
201712 0.701 104.011 0.888
201803 0.585 105.290 0.732
201806 0.619 106.317 0.767
201809 0.691 106.507 0.855
201812 0.790 105.998 0.982
201903 0.822 107.251 1.010
201906 0.848 108.070 1.034
201909 0.944 108.329 1.148
201912 0.894 108.420 1.087
202003 0.979 108.902 1.185
202006 1.067 108.767 1.293
202009 0.985 109.815 1.182
202012 0.925 109.897 1.109
202103 0.937 111.754 1.105
202106 0.934 114.631 1.074
202109 1.097 115.734 1.249
202112 1.057 117.630 1.184
202203 1.179 121.301 1.281
202206 1.243 125.017 1.310
202209 1.284 125.227 1.351
202212 1.119 125.222 1.178
202303 1.360 127.348 1.407
202306 1.356 128.729 1.388
202309 1.377 129.860 1.397
202312 1.340 129.419 1.364
202403 1.387 131.776 1.387

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


InfuSystems Holdings  (FRA:1TZ) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

InfuSystems Holdings's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=5.95/4.42
=1.35

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of InfuSystems Holdings was 6.41. The lowest was 0.46. And the median was 1.81.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


InfuSystems Holdings Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of InfuSystems Holdings's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


InfuSystems Holdings (FRA:1TZ) Business Description

Traded in Other Exchanges
Address
3851 West Hamlin Road, Rochester Hills, MI, USA, 48309
InfuSystems Holdings Inc is a United States based healthcare service provider. It offers Infusion pumps and related products and services for patients in the home, oncology clinics, ambulatory surgery centers, and other sites of care from the locations in the United States and Canada. The company provides products and services to hospitals, oncology practices and chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The segments of the company are Integrated Therapy Services (ITS) and Durable Medical Equipment (DME) services, of which key revenue is derived from the ITS segment.

InfuSystems Holdings (FRA:1TZ) Headlines

No Headlines